Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C brings $400mm to Relay Therapeutics

Executive Summary

Relay Therapeutics Inc. (protein motion-based drug discovery; initial focus in oncology) raised $400mm through its Series C round from SoftBank Vision Fund (lead), new investors including Foresite Capital, Perceptive Advisors, and Tavistock Group, and returning backers GV, Casdin Capital, BVF Partners, EcoR1 Capital, Alexandria Venture Investments, and an affiliate of D.E. Shaw Research. This is the second-largest venture round in Strategic Transactions, behind Moderna Therapeutics' $450mm Series C in 2015.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies